The Ensign Group, Inc. (ENSG) VP exercises options, sells stock on 10b5-1 plan

Rhea-AI Filing Summary

The Ensign Group, Inc. reported an insider stock transaction by its VP and Chief Legal Officer. On December 12, 2025, the officer exercised 2,500 employee stock options at an exercise price of $44.84 per share, acquiring the same number of common shares.

On the same date, the officer sold 1,000, 5,846 and 1,554 shares of common stock at weighted average sale prices of $174.1075, $175.516 and $176.207, respectively, leaving 32,779 common shares owned directly after the transactions and no remaining derivative securities. The activity was effected under a Rule 10b5-1 trading plan adopted on September 2, 2025, using options originally granted on May 28, 2020 that vest over five equal annual installments.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wittekind Beverly B.

(Last) (First) (Middle)

29222 RANCHO VIEJO ROAD

SUITE 127

(Street)

SAN JUAN CAPISTRANO CA 92675

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ENSIGN GROUP, INC [ ENSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP and Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		M(1)		2,500	A	$44.84	41,179	D
Common Stock	12/12/2025		S(1)		1,000	D	$174.1075(2)	40,179	D
Common Stock	12/12/2025		S(1)		5,846	D	$175.516(3)	34,333	D
Common Stock	12/12/2025		S(1)		1,554	D	$176.207(4)	32,779	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$44.84	12/12/2025		M(1)			2,500	05/28/2021(5)	05/28/2030	Common Stock	2,500	$0	0	D

Explanation of Responses:

1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.

2. This transaction was executed in multiple trades at prices ranging from $173.80 to $174.645. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

3. This transaction was executed in multiple trades at prices ranging from $174.97 to $175.95. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. This transaction was executed in multiple trades at prices ranging from $176.00 to $176.46. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

5. These shares were granted May 28, 2020 and vested over 5 equal annual installments.

Remarks:

	/s/ Chad A. Keetch, as power of attorney	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transaction did Ensign Group (ENSG) disclose?

An Ensign Group VP and Chief Legal Officer exercised 2,500 employee stock options and sold common stock in several trades on December 12, 2025.

How many Ensign Group (ENSG) options were exercised and at what price?

The officer exercised 2,500 employee stock options with an exercise price of $44.84 per share, receiving the same number of common shares.

How many Ensign Group (ENSG) shares were sold and at what prices?

The officer sold 1,000, 5,846 and 1,554 Ensign Group common shares at weighted average prices of $174.1075, $175.516 and $176.207, respectively.

How many Ensign Group (ENSG) shares does the officer own after these trades?

After the reported transactions, the officer beneficially owns 32,779 shares of Ensign Group common stock directly.

Were the Ensign Group (ENSG) insider transactions under a Rule 10b5-1 plan?

Yes. The filing states the transactions were effected under a Rule 10b5-1 trading plan adopted on September 2, 2025.

What are the key dates for the options used in this Ensign Group (ENSG) transaction?

The employee stock options were granted on May 28, 2020, vested over five equal annual installments, became exercisable on May 28, 2021, and have an expiration date of May 28, 2030.